Table 1. Baseline characteristics and laboratory findings of the groups and relationship between NLR distribution and long-term follow-up.

	T.1 (≤1.87) (n=37)	T.2 (1.88-3.87) (n=36)	T.3 (≥3.88) (n=38)	P value
Age, y	49.8 ± 10.4	54.3 ± 8.6	47.7 ± 10.9	0.02
Male sex (n%)	27 (%72.9)	20 (%55)	28 (%73.6)	0.17
Hypertension (n%)	12 (%32)	19 (%52.7)	15 (%39)	0.20
Diabetes mellitus (n%)	2 (%5.4)	4 (%11.1)	3 (%7.9)	0.67
Hyperlipidemia (n%)	7 (%18.9)	9 (%25)	8 (%21.0)	0.26
Smoking (n%)	18 (%48.6)	19 (%52.7)	27 (%71)	0.04
BMI, mean ± SD, kg/m2	25.3 ± 2.3	25.8 ± 2.5	25.3 ± 2.6	0.67
Family history, (n%)	12 (%32.4)	7 (%19.4)	13 (%34.2)	0.31
WBC, mean ± SD, x103/uL	8.35 ± 1.98	8.44 ± 1.82	9.9 ± 2.71	0.01
Hb,mean ± SD, g/dL	14.6 ± 1.7	13.7 ± 1.2	14.1 ± 1.2	0.20
N/Lmean ± SD	1.32 ± 0.3	2.75 ± 0.53	5.78 ± 2.13	0.01
Platelet, mean ± SD, 103/uL	246 ± 55	248 ± 50	236 ± 51	0.61
BUN,mean ± SD, mg/dL	16.9 ± 16.4	16.4 ± 9.8	19 ± 7.4	0.54
Creatinine, mean ± SD, mg/dL	0.89 ± 0.18	0.81 ± 0.17	0.86 ± 0.18	0.15
CK-MB, [IQR] ng/mL	22 [19]	20 [16.2]	24 [19.5]	0.72
Total cholesterol, mean ± SD, mg/dL	191 ± 50	181 ± 36	185 ± 44	0.66
Triglycerides, mean ± SD, mg/dL	170 ± 70	162 ± 70	160 ± 90	0.66
HDL,mean ± SD, mg/dL	41 ± 12	40 ± 8	42 ± 10	0.64
LDL,mean ± SD, mg/dL	116 ± 43	111 ± 34	118 ± 40	0.71
CRP, [IQR] mg/dL	0.5 [0.75]	0.7 [0.75]	1.1 [2.4]	0.01
Troponin I, [IQR] ng/ml	0,02 [0,15]	0,03 [1,1]	0,14 [2,1]	0,05
Recurrent angina, (n%)	9 (%24.3)	13 (%36.1)	26 (%68.4)	0.01
Recurrent MI, (n%)	4 (%10.8)	3 (%8.3)	14 (%36.8)	0.01
Death	0	1	0	--

Abbreviation: BUN, blood urea nitrogen; CK- MB, creatinin kinaz myocardial band; CRP, C-reactive-protein; Hb, hemoglobin ; HDL, high density lipoprotein; LDL, low density lipoprotein; N/L,neutrophil lymphocyte ratio; WBC, white blood cell